Stemina Biomarker Discovery, Inc.
Compound safety screening to improve human health
Stemina has pioneered development of all human, cell-based tests to screen compounds for their potential to cause birth defects or cardiotoxicity. Our devTOX quickPredict assay is highly predictive of developmental toxicity, as shown in a joint US EPA study published in Toxicological Sciences, and is the only commercially available human-based screen. Our Cardio quickPredict assay assesses structural and functional cardiotoxicity with high accuracy, as published in Toxicological Sciences.